Novartis Shows Importance Of Gene Therapy With AveXis Name Change
Swiss Major Renames AveXis As Novartis Gene Therapies
Novartis has completed its absorption of AveXis and rebranded the acquired gene therapy specialist that developed the soon-to-be SMA blockbuster Zolgensma despite struggling to meet the data integrity standards of regulators and big pharma.
